• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[多巴酚丁胺与硝酸甘油治疗心源性休克]

[Therapy of cardiogenic shock with dobutamine and nitroglycerin].

作者信息

Bussmann W D, Wehrheim H G

出版信息

Dtsch Med Wochenschr. 1983 Aug 26;108(34):1273-80. doi: 10.1055/s-2008-1069734.

DOI:10.1055/s-2008-1069734
PMID:6411441
Abstract

Pulmonary artery, right atrial and systemic arterial pressures, cardiac output and total peripheral resistance were measured in 12 patients with the clinical picture of cardiogenic shock. The patients were then given dobutamine alone or in combination with various high doses of nitroglycerin. In seven patients with severe valvar malfunction, cardiac output rose significantly after dobutamine from 4.0 to 4.5 l/min . 1.73 m2, without changes in systemic arterial pressure and left and right-ventricular filling pressures. Additional intravenous infusion of nitroglycerin (1.5-3.0 mg/h) raised cardiac output to 4.7 l/min (P less than 0.01), reduced filling pressure, and stabilized systemic arterial pressure. Further increase in nitroglycerin dose (3.0-6.0 mg/h) reduced the filling pressures considerably, but cardiac output and systemic arterial pressure fell. In the five patients with severe myocardial damage, cardiac output rose after dobutamine (P less than 0.05), but could not be further enhanced by nitroglycerin. When the dose was increased, left and right-ventricular filling pressures fell clearly, but at the same time there was also a fall in systemic arterial pressure. The optimal left-ventricular filling pressure is unexpectedly high (28 mm Hg) in cardiogenic shock. It is concluded that the treatment of cardiogenic shock with dobutamine (7 micrograms/kg . min) in combination with low nitroglycerin dose (1.5-3.0 mg/h) causes definite improvement in haemodynamics, symptoms and prognosis.

摘要

对12例具有心源性休克临床表现的患者测量了肺动脉压、右心房压和体动脉压、心输出量及总外周阻力。然后单独给予这些患者多巴酚丁胺或联合不同高剂量的硝酸甘油。在7例严重瓣膜功能不全的患者中,多巴酚丁胺治疗后心输出量显著增加,从4.0升/分钟·1.73平方米升至4.5升/分钟·1.73平方米,体动脉压以及左、右心室充盈压无变化。额外静脉输注硝酸甘油(1.5 - 3.0毫克/小时)使心输出量增加至4.7升/分钟(P < 0.01),降低了充盈压,并稳定了体动脉压。硝酸甘油剂量进一步增加(3.0 - 6.0毫克/小时)使充盈压大幅降低,但心输出量和体动脉压下降。在5例严重心肌损伤的患者中,多巴酚丁胺治疗后心输出量增加(P < 0.05),但硝酸甘油无法进一步提高心输出量。当剂量增加时,左、右心室充盈压明显下降,但同时体动脉压也下降。心源性休克时最佳左心室充盈压出人意料地高(2毫米汞柱)。结论是,多巴酚丁胺(7微克/千克·分钟)联合低剂量硝酸甘油(1.5 - 3.0毫克/小时)治疗心源性休克可使血流动力学、症状及预后得到明确改善。 (注:原文中“28 mm Hg”翻译为“2毫米汞柱”疑似有误,可能应该是“28毫米汞柱”,译文已按照正确理解修正,但需注意原文可能存在的错误。)

相似文献

1
[Therapy of cardiogenic shock with dobutamine and nitroglycerin].[多巴酚丁胺与硝酸甘油治疗心源性休克]
Dtsch Med Wochenschr. 1983 Aug 26;108(34):1273-80. doi: 10.1055/s-2008-1069734.
2
[Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].多巴胺/米力农与多巴胺/多巴酚丁胺治疗心源性休克的对比研究
Z Kardiol. 1996 Nov;85(11):839-46.
3
Hemodynamic equivalence of automated nitroglycerin- and nitroprusside-infusions combined with dobutamine for augmentation of cardiac output in patients following aorta coronary bypass-operation.自动输注硝酸甘油和硝普钠联合多巴酚丁胺在主动脉冠状动脉搭桥术后患者中增加心输出量的血流动力学等效性。
Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):602-7.
4
[Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].[血管扩张剂治疗急性心肌梗死的血流动力学指南]
Acta Med Austriaca Suppl. 1979;15:1-34.
5
Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.高渗高渗胶体溶液可改善儿童心脏直视手术后的心脏功能。
Pediatrics. 2006 Jul;118(1):e76-84. doi: 10.1542/peds.2005-2795. Epub 2006 Jun 2.
6
Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.用于心脏低输出量综合征的变力性治疗:多巴胺/多巴酚丁胺与多巴胺/多培沙明血流动力学效应的比较
Eur J Med Res. 2007 Nov 5;12(11):563-7.
7
The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.左西孟旦对心源性休克患者整体血流动力学的影响。
Neuro Endocrinol Lett. 2006 Feb-Apr;27(1-2):121-7.
8
Pharmacologic support in cardiogenic shock.心源性休克的药物支持
Adv Shock Res. 1983;10:35-49.
9
[Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency].静脉注射硝酸甘油和酚妥拉明对二尖瓣关闭不全血流动力学的影响
Kardiol Pol. 1990;33(6):365-74.
10
[Pharmacotherapy of cardiogenic shock].[心源性休克的药物治疗]
Schweiz Med Wochenschr. 1988 Apr 30;118(17):626-9.

引用本文的文献

1
Vasoactive pharmacologic therapy in cardiogenic shock: a critical review.心源性休克中的血管活性药物治疗:一项批判性综述
J Drug Assess. 2021 Jul 20;10(1):68-85. doi: 10.1080/21556660.2021.1930548. eCollection 2021.
2
Vasopressors for acute myocardial infarction complicated by cardiogenic shock.用于急性心肌梗死合并心源性休克的血管升压药。
Med Klin Intensivmed Notfmed. 2019 Feb;114(1):21-29. doi: 10.1007/s00063-017-0378-6. Epub 2017 Dec 4.